Most Recent
AFT Pharmaceuticals is seeking to reopen a lawsuit against Reckitt Benckiser over ads for its painkiller Maxigesic after judgment was delivered in the matter, claiming the judge's declarations contained an error, an argument slammed by Reckitt as "extraordinary".
AFT Pharmaceuticals has lost its challenge to a ruling that ads claiming its painkiller Maxigesic is more effective than Nuremol were misleading and deceptive, with the Full Federal Court saying the primary judge did not err in finding the ads lacked an adequate scientific basis.
Herbert Smith Freehills cannot recover its costs for successfully representing itself in litigation with United Petroleum over the company's aborted initial public offering, with an appeals court finding the High Court's recent ruling eliminating the so-called Chorley exception for self-represented lawyers applies to law firms as well.
Multiplex is calling for the liquidators of collapsed engineering services group Hastie to pay its costs, and pay now, for pursuing an action to recover millions of dollars in unpaid bills on the grounds that the construction company was not entitled to offset its debts with amounts owing.
AFT Pharmaceuticals has challenged a Federal Court decision that found its Maxisegic ads were misleading and deceptive, saying the judge "set the bar too high" by requiring it to prove there was an adequate scientific foundation for its painkiller representations.
Australia's largest potato wholesaler Mitolo Group will pay a penalty of $240,000 to resolve the consumer regulator's case alleging its contracts with growers were unfair.
The High Court will not review an appeals court's decision to approve a $64 million settlement in litigation over the failure of Banksia Securities while rejecting the funder's commission and legal fees.
Judgment is expected next week in the Australian Competition and Consumer Commission's case against Pacific National alleging the rail company made an anti-competitive bid for Aurizon's Acacia Ridge Terminal and intermodal freight business.
AFT Pharmaceuticals has accused rival Reckitt Benckiser of using the court as a "clearance house" to beat its competitors, the latest development in a long-running dispute over AFT's Maxigesic ads.
AFT Pharmaceuticals has agreed to a court order temporarily restraining it from distributing point of sale material containing updated claims that its painkiller Maxigesic is more effective than other over-the-counter medications.